VEL

DRUG3 trials

Sponsors

Gilead Sciences

Conditions

Chronic Hepatitis CHepatitis C

Phase 2

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

CompletedNCT01826981

Gilead SciencesChronic Hepatitis C

Start: 2013-04-30End: 2015-05-31Updated: 2018-11-16

Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection

CompletedNCT01858766

Gilead SciencesHepatitis C

Start: 2013-04-30End: 2014-08-31Updated: 2018-11-14

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

CompletedNCT01909804

Gilead SciencesHepatitis C

Start: 2013-06-30End: 2014-08-31Updated: 2018-11-15

Related Papers

Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.

2022-06-083 citations

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.

2015-11-1081 citations

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.

2015-11-1066 citations

Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.

2015-08-07128 citations